Dangerous Ideas In Drug Development

NSW Early Phase Clinical Trials Alliance (NECTA)
  • 0.0 (0)
  • MEDICINE
  • UPDATED MONTHLY

Join our hosts from the NSW Early Phase Clinical Trials Alliance as they interview guests from across the early drug development industry. We'll be discussing the latest novel agents that are breaking ground in oncology around the world.

  1. 12/23/2025

    ctDNA with Natera

    Join us as we bring the year to a close by chatting with Dr Rob Lentz from Natera about how circulating tumour DNA testing can inform better treatment decisions in the clinic. We hear about the power of ctDNA alongside reference tumour informed testing and the latest data supporting it's use in GI as well as many other cancers.

    28 min

  2. 11/13/2025

    Precision AI with Artera

    Join us this episode as we talk with Artera, a company leading in the AI space with personalised prognostic insights in cancer care. We learn about this fascinating development of AI in digital pathology which can be rolled out across demographics with predictive applications in prostate and other cancer streams.

    31 min
  3. NECTA Meeting 2025 - CINSW and decentralised precision medicine

    04/09/2025

    NECTA Meeting 2025 - CINSW and decentralised precision medicine

    Talk 1: Maria Mury, Cancer Institute New South Wales: CINSW, supporting clinical trials and cancer careTalk 2: Dr Matthew Krebs, Manchester Cancer Research Centre: Practical aspects on new generation precision medicine in 2025

    1h 32m
  4. NECTA Meeting 2025 - Precision oncology in brain tumours

    04/08/2025

    NECTA Meeting 2025 - Precision oncology in brain tumours

    Talk 1: A/Prof Pratiti (Mimi) Bandopadhayay, Dana Farber Cancer Institute: Emerging precision oncology in brain tumoursTalk 2: Dr Frank Lin, UNSW: Integrating IT tools into trials of precision oncology

    1h 12m
  5. NECTA Meeting 2025 - Latest advances in theranostics for oncology

    04/08/2025

    NECTA Meeting 2025 - Latest advances in theranostics for oncology

    Talk 1: Prof Louise Emmett, St Vincent’s Hospital Sydney: Latest advances in theranostics for oncology Talk 2: Prof Shaneen Sandhu, Peter MacCallum Cancer Centre: Embedding translational science in radio medical oncology

    1h 3m
  6. NECTA Meeting 2025 - Insights for Australian oncology professionals

    04/08/2025

    NECTA Meeting 2025 - Insights for Australian oncology professionals

    Highlight Talk 1 -  Dr Jordan Cohen, Calvary Mater Newcastle: Decentralised clinical trials innovation and practice Highlight Talk 2 -  Dr Connie Diakos, Royal North Shore Hospital Sydney: North Star VNP: a model for international collaboration Highlight Talk 3 -  Prof Jayesh Desai, Peter MacCallum Cancer Centre: Clinical trials within the Victorian ecosystem

    1h 3m
  7. NECTA Meeting 2025 - New advances in synthetic lethality in cancer

    04/08/2025

    NECTA Meeting 2025 - New advances in synthetic lethality in cancer

    Speaker: Prof William Sellers, Broad Institute Harvard

    1 hr

  8. 02/27/2025

    Cancer Care and the Cancer Institute NSW

    Tune in this time to find out more about NSW's lead cancer control agency - Cancer Insitute NSW. We are joined by Prof Tracey O'Brien, Chief Cancer Officer to talk about her career to date and insights into CINSW's work across the state.

    30 min
See All (21)

About

Join our hosts from the NSW Early Phase Clinical Trials Alliance as they interview guests from across the early drug development industry. We'll be discussing the latest novel agents that are breaking ground in oncology around the world.

Information

  • Creator
    NSW Early Phase Clinical Trials Alliance (NECTA)
  • Years Active
    2023 - 2025
  • Episodes
    21
  • Rating
    Clean
  • Copyright
    © NSW Early Phase Clinical Trials Alliance (NECTA)
  • Show Website
    Dangerous Ideas In Drug Development